Table of Content

1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Overview
1.1 Product Overview and Scope of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
1.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Segment by Type
1.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Live Vaccine
1.2.3 Inactivated Vaccine
1.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Segment by Application
1.3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Value by Application: (2024-2034)
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue 2024-2034
1.4.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales 2024-2034
1.4.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Manufacturers (2024-2024)
2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Manufacturers (2024-2024)
2.4 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, Product Type & Application
2.7 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Competitive Situation and Trends
2.7.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Players Market Share by Revenue
2.7.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Retrospective Market Scenario by Region
3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region: 2024-2034
3.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region: 2024-2024
3.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region: 2024-2034
3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region: 2024-2034
3.3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region: 2024-2024
3.3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region: 2024-2034
3.4 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2034)
3.4.3 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2034)
3.5.3 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2034)
3.6.3 Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2034)
3.7.3 Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2034)
3.8.3 Middle East and Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2024-2034)
4.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2024-2024)
4.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Type (2024-2034)
4.1.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2024-2034)
4.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Type (2024-2034)
4.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Type (2024-2024)
4.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Type (2024-2034)
4.2.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Type (2024-2034)
4.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price by Type (2024-2034)
5 Segment by Application
5.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2024-2034)
5.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2024-2024)
5.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Application (2024-2034)
5.1.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2024-2034)
5.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Application (2024-2034)
5.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Application (2024-2024)
5.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Application (2024-2034)
5.2.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Application (2024-2034)
5.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Zoetis Animal Health
6.1.1 Zoetis Animal Health Corporation Information
6.1.2 Zoetis Animal Health Description and Business Overview
6.1.3 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.1.5 Zoetis Animal Health Recent Developments/Updates
6.2 Boehringer-Ingelheim
6.2.1 Boehringer-Ingelheim Corporation Information
6.2.2 Boehringer-Ingelheim Description and Business Overview
6.2.3 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.2.5 Boehringer-Ingelheim Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Corporation Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Corporation Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 MSD Animal Health
6.5.1 MSD Animal Health Corporation Information
6.5.2 MSD Animal Health Description and Business Overview
6.5.3 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.5.4 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.5.5 MSD Animal Health Recent Developments/Updates
6.6 SPAH
6.6.1 SPAH Corporation Information
6.6.2 SPAH Description and Business Overview
6.6.3 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.6.4 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.6.5 SPAH Recent Developments/Updates
6.7 Nanjing Tianbang Biological Technology
6.6.1 Nanjing Tianbang Biological Technology Corporation Information
6.6.2 Nanjing Tianbang Biological Technology Description and Business Overview
6.6.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.7.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
6.8 Sichuan Huapai Bio-pharmaceutical
6.8.1 Sichuan Huapai Bio-pharmaceutical Corporation Information
6.8.2 Sichuan Huapai Bio-pharmaceutical Description and Business Overview
6.8.3 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.8.5 Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
6.9 Guangdong Winsun Bio Pharmaceutical
6.9.1 Guangdong Winsun Bio Pharmaceutical Corporation Information
6.9.2 Guangdong Winsun Bio Pharmaceutical Description and Business Overview
6.9.3 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.9.5 Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
6.10 Wuhan Keqian Biology
6.10.1 Wuhan Keqian Biology Corporation Information
6.10.2 Wuhan Keqian Biology Description and Business Overview
6.10.3 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.10.5 Wuhan Keqian Biology Recent Developments/Updates
6.11 Shanghai Hile Bio-Technology
6.11.1 Shanghai Hile Bio-Technology Corporation Information
6.11.2 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Description and Business Overview
6.11.3 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
6.12 Harbin Pharmaceutical Group Bio-Vaccine
6.12.1 Harbin Pharmaceutical Group Bio-Vaccine Corporation Information
6.12.2 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Description and Business Overview
6.12.3 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
6.13 Ringpu
6.13.1 Ringpu Corporation Information
6.13.2 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Description and Business Overview
6.13.3 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.13.5 Ringpu Recent Developments/Updates
6.14 Shandong Huahong Bioengineering
6.14.1 Shandong Huahong Bioengineering Corporation Information
6.14.2 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Description and Business Overview
6.14.3 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.14.5 Shandong Huahong Bioengineering Recent Developments/Updates
6.15 Weike Biotechnology
6.15.1 Weike Biotechnology Corporation Information
6.15.2 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Description and Business Overview
6.15.3 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.15.5 Weike Biotechnology Recent Developments/Updates
6.16 Nanjing Tianbang Biological Technology
6.16.1 Nanjing Tianbang Biological Technology Corporation Information
6.16.2 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Description and Business Overview
6.16.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.16.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
6.17 China Animal Husbandry Industry
6.17.1 China Animal Husbandry Industry Corporation Information
6.17.2 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Description and Business Overview
6.17.3 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.17.4 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Portfolio
6.17.5 China Animal Husbandry Industry Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Chain Analysis
7.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Mode & Process
7.4 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales and Marketing
7.4.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Channels
7.4.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors
7.5 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Customers
8 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Dynamics
8.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Trends
8.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Drivers
8.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Challenges
8.4 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses) of Key Manufacturers (2024-2024)
Table 5. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price (US$/Dose) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2024-2024) & (K Doses)
Table 18. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Region (2024-2024)
Table 19. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2024-2034) & (K Doses)
Table 20. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Region (2024-2024)
Table 23. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 27. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 28. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 32. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 33. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2024-2024) & (K Doses)
Table 37. Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Region (2024-2034) & (K Doses)
Table 38. Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 42. Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 43. Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 47. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 48. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses) by Type (2024-2024)
Table 51. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses) by Type (2024-2034)
Table 52. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2024-2024)
Table 53. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Type (2024-2024)
Table 57. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price (US$/Dose) by Type (2024-2024)
Table 59. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price (US$/Dose) by Type (2024-2034)
Table 60. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses) by Application (2024-2024)
Table 61. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses) by Application (2024-2034)
Table 62. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2024-2024)
Table 63. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Application (2024-2024)
Table 67. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price (US$/Dose) by Application (2024-2024)
Table 69. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price (US$/Dose) by Application (2024-2034)
Table 70. Zoetis Animal Health Corporation Information
Table 71. Zoetis Animal Health Description and Business Overview
Table 72. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 73. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 74. Zoetis Animal Health Recent Developments/Updates
Table 75. Boehringer-Ingelheim Corporation Information
Table 76. Boehringer-Ingelheim Description and Business Overview
Table 77. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 78. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 79. Boehringer-Ingelheim Recent Developments/Updates
Table 80. Merck Animal Health Corporation Information
Table 81. Merck Animal Health Description and Business Overview
Table 82. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 83. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 84. Merck Animal Health Recent Developments/Updates
Table 85. Ceva Santé Animale Corporation Information
Table 86. Ceva Santé Animale Description and Business Overview
Table 87. Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 88. Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 89. Ceva Santé Animale Recent Developments/Updates
Table 90. MSD Animal Health Corporation Information
Table 91. MSD Animal Health Description and Business Overview
Table 92. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 93. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 94. MSD Animal Health Recent Developments/Updates
Table 95. SPAH Corporation Information
Table 96. SPAH Description and Business Overview
Table 97. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 98. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 99. SPAH Recent Developments/Updates
Table 100. Nanjing Tianbang Biological Technology Corporation Information
Table 101. Nanjing Tianbang Biological Technology Description and Business Overview
Table 102. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 103. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 104. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 105. Sichuan Huapai Bio-pharmaceutical Corporation Information
Table 106. Sichuan Huapai Bio-pharmaceutical Description and Business Overview
Table 107. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 108. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 109. Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
Table 110. Guangdong Winsun Bio Pharmaceutical Corporation Information
Table 111. Guangdong Winsun Bio Pharmaceutical Description and Business Overview
Table 112. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 113. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 114. Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
Table 115. Wuhan Keqian Biology Corporation Information
Table 116. Wuhan Keqian Biology Description and Business Overview
Table 117. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 118. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Shanghai Hile Bio-Technology Corporation Information
Table 121. Shanghai Hile Bio-Technology Description and Business Overview
Table 122. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 123. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 124. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 125. Harbin Pharmaceutical Group Bio-Vaccine Corporation Information
Table 126. Harbin Pharmaceutical Group Bio-Vaccine Description and Business Overview
Table 127. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 128. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 129. Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
Table 130. Ringpu Corporation Information
Table 131. Ringpu Description and Business Overview
Table 132. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 133. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 134. Ringpu Recent Developments/Updates
Table 135. Shandong Huahong Bioengineering Corporation Information
Table 136. Shandong Huahong Bioengineering Description and Business Overview
Table 137. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 138. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 139. Shandong Huahong Bioengineering Recent Developments/Updates
Table 140. Weike Biotechnology Corporation Information
Table 141. Weike Biotechnology Description and Business Overview
Table 142. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 143. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 144. Weike Biotechnology Recent Developments/Updates
Table 145. Nanjing Tianbang Biological Technology Corporation Information
Table 146. Nanjing Tianbang Biological Technology Description and Business Overview
Table 147. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 148. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 149. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 150. China Animal Husbandry Industry Corporation Information
Table 151. China Animal Husbandry Industry Description and Business Overview
Table 152. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 153. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product
Table 154. China Animal Husbandry Industry Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors List
Table 158. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Customers List
Table 159. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Trends
Table 160. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Drivers
Table 161. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Challenges
Table 162. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Figure 2. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Share by Type in 2022 & 2034
Figure 4. Live Vaccine Product Picture
Figure 5. Inactivated Vaccine Product Picture
Figure 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Share by Application in 2022 & 2034
Figure 8. Piglets
Figure 9. Adults Pigs
Figure 10. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 11. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size (2024-2034) & (US$ Million)
Figure 12. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (2024-2034) & (K Doses)
Figure 13. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price (US$/Dose) & (2024-2034)
Figure 14. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Report Years Considered
Figure 15. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Players: Market Share by Revenue in 2022
Figure 18. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 19. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 20. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2024-2034)
Figure 21. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2024-2034)
Figure 22. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 23. Canada Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2024-2034)
Figure 25. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2024-2034)
Figure 26. Germany Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. France Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. U.K. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Italy Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Russia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Region (2024-2034)
Figure 32. Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Region (2024-2034)
Figure 33. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Australia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. China Taiwan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2024-2034)
Figure 41. Latin America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2024-2034)
Figure 42. Mexico Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Brazil Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Argentina Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share by Country (2024-2034)
Figure 46. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Country (2024-2034)
Figure 47. Turkey Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Saudi Arabia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. UAE Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Global Sales Market Share of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Type (2024-2034)
Figure 51. Global Revenue Market Share of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Type (2024-2034)
Figure 52. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price (US$/Dose) by Type (2024-2034)
Figure 53. Global Sales Market Share of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Application (2024-2034)
Figure 54. Global Revenue Market Share of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Application (2024-2034)
Figure 55. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price (US$/Dose) by Application (2024-2034)
Figure 56. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Value Chain
Figure 57. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed